Download PDF
Deutsche Zeitschrift für Onkologie 2020; 52(02): 81-89
DOI: 10.1055/a-1161-4175
Praxis – Behandlungsprobleme

Nebenwirkungen komplementär behandeln

Complementary Therapies for the Treatment of Adverse Effects
Nicole Weis
› Further Information
    Permissions and Reprints

Zusammenfassung

In der supportiven Onkologie werden zunehmend Verfahren aus dem Bereich der Naturheilkunde ergänzend eingesetzt, um Nebenwirkungen zu lindern. Dieser Artikel gibt eine Übersicht der wichtigsten Symptome und beschreibt anhand dessen komplementäre Therapiemöglichkeiten, die sich in Studien beziehungsweise in der Praxis bewährt haben.

Abstract

In supportive oncology, methods from the field of naturopathy are increasingly used to reduce adverse effects. This article provides an overview of the most important symptoms and it describes options of complementary therapies that were proven in studies or in clinical practice.

Schlüsselwörter

Nebenwirkungen - komplementäre Therapie - supportive Therapie - CAM-Verfahren - Brustkrebs - Lebensqualität - Chemotherapie

Key words

Adverse effects - complementary therapy - supportive therapy - CAM methods - breast cancer - quality of life - chemotherapy


Publication History

Article published online:
28 June 2020

© Georg Thieme Verlag KG
Stuttgart · New York

 

  • Literatur

  • 1 Ballard-Barbash R, Friedenreich CM, Courneya KS. et al. Physical activity, biomarkers, and disease outcomes in cancer survivors: A systematic review. J Natl Cancer Inst 2012; 104: 815-840
    CrossrefPubMedGoogle Scholar
  • 2 Biswal BM, Zakaria A, Ahmad NM. Topical application of honey in the management of radiation mucositis: a preliminary study. Support Care Cancer 2003; 11: 242-248
    CrossrefPubMedGoogle Scholar
  • 3 Boehm K, Ostermann T, Milazzo S, Büssing A. Effects of yoga interventions on fatigue: a meta-analysis. Evid Based Complement Alternat Med 2012; 2012: 124703
    PubMedGoogle Scholar
  • 4 Bruns F, Büntzel J, Mücke R. et al. Selenium in the treatment of head and neck lymphedema. Med Princ Pract 2004; 13: 185-190
    CrossrefPubMedGoogle Scholar
  • 5 Büssing A, Ostermann T, Matthiessen PF. Inanspruchnahme unterstützender komplementärmedizinischer Verfahren bei Tumorpatienten in der späteren Phase. Dtsch Z Onkol 2007; 39: 162-168
    PubMedGoogle Scholar
  • 6 Chang WP, Peng YX. Does the oral administration of ginger reduce chemotherapy-induced nausea and vomiting?: A meta-analysis of 10 randomized controlled trials. Cancer Nurs 2019; 42: E14-E23
    CrossrefPubMedGoogle Scholar
  • 7 Chao LF, Zhang AL, Liu HE. et al. The efficacy of acupoint stimulation for the management of therapy related adverse events in patients with breast cancer: a systematic review. Breast Cancer Res Treat 2009; 118: 255-267
    CrossrefPubMedGoogle Scholar
  • 8 Chen L, Lin CC, Huang TW. et al. Effect of acupuncture on aromatase inhibitor-induced arthralgia in patients with breast cancer: A meta-analysis of randomized controlled trials. Breast (Edinburgh, Scotland) 2017; 33: 132-138
    CrossrefPubMedGoogle Scholar
  • 9 Chirgwin JH, Giobbie-Hurder A, Coates AS. et al. Treatment adherence and its impact on disease-free survival in the Breast International Group 1-98 Trial of tamoxifen and letrozole, alone and in sequence. J Clin Oncol 2016; 34: 2452-2459
    CrossrefPubMedGoogle Scholar
  • 10 Ernst A, Klein S. Komplementäre und alternative Methoden bei Krebs einordnen und bewerten. Dtsch Med Wochenschr 2017; 142: 873-881
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Ezzo J, Vickers A, Richardson MA. et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol 2005; 23: 7188-7198
    CrossrefPubMedGoogle Scholar
  • 12 Friedenreich CM, Neilson HK, Farris MS, Courneya KS. Physical activity and cancer outcomes: a precision medicine approach. Clin Cancer Res 2016; 22: 4766-4774
    CrossrefPubMedGoogle Scholar
  • 13 Garcia MK, Cohen L, Spano M. et al. Inpatient acupuncture at a major cancer center. Integr Cancer Ther 2018; 17: 148-152
    CrossrefPubMedGoogle Scholar
  • 14 Hasenberg T, Essenbreis M, Herold A. et al. Early supplementation of parenteral nutrition is capable ofimproving quality of life, chemotherapy-related toxicity and body composition in patients with advanced colorectalcarcinoma undergoing palliative treatment: results from aprospective, randomized clinical trial. Colorectal Dis 2010; 12: 190-199
    PubMedGoogle Scholar
  • 15 Hassan H, Rompola M, Glaser AW. et al. Systematic review and meta-analysis investigating the efficacy and safety of probiotics in people with cancer. Support Care Cancer 2018; 26: 2503-2509
    CrossrefPubMedGoogle Scholar
  • 16 Hierl M, Pfirstinger J, Andreesen R. et al. Complementary and alternative medicine: a clinical study in 1,016 hematology/oncology patients. Oncology 2017; 93: 157-163
    CrossrefPubMedGoogle Scholar
  • 17 Hilfiker R, Meichtry A, Eicher M. et al. Exercise and other non-pharmaceutical interventions for cancer-related fatigue in patients during or after cancer treatment: a systematic review incorporating an indirect-comparisons meta-analysis. Br J Sports Med 2018; 52: 651-658
    CrossrefPubMedGoogle Scholar
  • 18 Holmes MD, Chen WY, Feskanich D. et al. Physical activity and survival after breast cancer diagnosis. JAMA 2005; 293: 2479-2486
    CrossrefPubMedGoogle Scholar
  • 19 Holzhauer P. Mit Bedacht kombinieren. DHZ – Deutsche Heilpraktiker Zeitschrift 2017; 12 (4): 32-39
    PubMedGoogle Scholar
  • 20 Holzhauer P, Koula-Jenik H, Pempelfort K, Schneider B. Prophylaxe der Chemotherapie-assoziierten oralen Mukositis. Dtsch Z Onkol 2015; 47: 36-40
    PubMedGoogle Scholar
  • 21 Irwin ML, Smith AW, McTiernan A. et al. Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study. J Clin Oncol 2008; 26: 3958-3964
    CrossrefPubMedGoogle Scholar
  • 22 Kaufmann M, Ernst B. Was Frauen mit Krebs erfahren, empfinden, wissen und vermissen. CAWAC-Umfrage in Deutschland. Deutsches Ärztebl 2000; 97: 3191-3196
    PubMedGoogle Scholar
  • 23 Kassab S, Cummings M, Berkovitz S. et al. Homeopathic medicines for adverse effects of cancer treatments. Cochrane Database Syst Rev 2009; (2): CD004845. DOI: 10.1002/14651858.CD004845.pub2.
    CrossrefPubMedGoogle Scholar
  • 24 Khan QJ, Kimler BF, Reddy PS. et al. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial. Breast Cancer Res Treat 2017; 166: 491-500
    CrossrefPubMedGoogle Scholar
  • 25 Khan QJ, Kimler BF, Reddy PS. et al. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms and fatigue in women with breast cancer starting adjuvant letrozole: The VITAL trial. J Clin Oncol 2012; 30: 2012.-suppl; abstr 9000
    CrossrefPubMedGoogle Scholar
  • 26 Kienle GS, Kiene H. Influence of Viscum album L (European mistletoe) extracts on quality of life in cancer patients: a systematic review of controlled clinical studies. Integr Cancer Ther 2010; 9: 142-157
    CrossrefPubMedGoogle Scholar
  • 27 Knols R, Aaronson NK, Uebelhart D. et al. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol 2005; 23: 3830-3842
    CrossrefPubMedGoogle Scholar
  • 28 Kröz M, Reif M, Glinz A. et al. Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue – results of a three-armed pragmatic trial in a comprehensive cohort design. BMC Cancer 2017; 17: 166
    CrossrefPubMedGoogle Scholar
  • 29 Kronabel D. Interaktionen von Lebensmitteln und Onkologika: Die klinische Relevanz ist entscheidend. Dtsch Z Onkol 2016; 48: 100-104
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Ku CF, Koo M. Association of distress symptoms and use of complementary medicine among patients with cancer. J Clin Nursing 2012; 21: 736-744
    CrossrefPubMedGoogle Scholar
  • 31 Lipp HP. Wechselwirkungsrisiken mit zielgerichtet wirksamen, oralen Tumortherapeutika – ein Überblick. Dtsch Z Onkol 2017; 49: 38-42
    PubMedGoogle Scholar
  • 32 Lötzke D. Yoga als begleitende Intervention während der Chemotherapie: Welche positiven Effekte sind belegt?. Dtsch Z Onkol 2015; 47: 160-164
    PubMedGoogle Scholar
  • 33 Lötzke D, Wiedemann F, Rodrigues Recchia D. et al. Iyengar-Yoga compared to exercise as a therapeutic intervention during (neo)adjuvant therapy in women with stage I-III breast cancer: Health-related quality of life, mindfulness, spirituality, life satisfaction, and cancer-related fatigue. Evid Based Complement Alternat Med 2016; 2016: 5931816
    PubMedGoogle Scholar
  • 34 Meneses-Echavez JF, Gonzales-Jimenez E, Correa-Bautista JE. et al. Effectiveness of physical exercise on fatigue in cancer patients during active treatment: a systematic review and meta-analysis. Cad Saude Publica 2015; 31: 667-681
    CrossrefPubMedGoogle Scholar
  • 35 Muecke R, Schomburg L, Glatzel M et al.German Working Group Trace Elements and Electrolytes in Oncology-AKTE. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 2010; 78: 828–835
    PubMed
  • 36 Mohsin AHB, Reddy SV, Kumar MP, Samee S. Aloe vera for dry mouth denture patients-palliative therapy. J Clin Diagn Res 2017; 11: ZC20-ZC23
    PubMedGoogle Scholar
  • 37 Nagi R, Patil DJ, Rakesh N. et al. Natural agents in the management of oral mucositis in cancer patients – systematic review. J Oral Biol Craniofacial Res 2018; 8: 245-254
    PubMedGoogle Scholar
  • 38 Oberbaum M, Yaniv I, Ben-Gal Y. et al. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer 2001; 92: 684-900
    CrossrefPubMedGoogle Scholar
  • 39 Rastelli AL, Taylor ME, Gao F. et al. Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat 2011; 129: 107-116
    CrossrefPubMedGoogle Scholar
  • 40 Sohl SJ, Weaver KE, Birdee G. et al. Characteristics associated with the use of complementary health approaches among long-term cancer survivors. Supportive Cancer Care 2014; 22: 927-936
    CrossrefPubMedGoogle Scholar
  • 41 Steindorf K, Schmidt ME, Klassen O. et al. Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life. Ann Oncol 2014; 25: 2237-2243
    CrossrefPubMedGoogle Scholar
  • 42 Stone P, Richardson A, Ream E. et al. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 2000; 11: 971-975
    CrossrefPubMedGoogle Scholar
  • 43 Unger C, Häring B, Kruse A. et al. Double-blind randomised placebo-controlled phase III study of an E. coli extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced colorectal cancer. Arzneim Forsch/Drug Res 2001; 51: 332-338
    PubMedGoogle Scholar
  • 44 Van Waart H, Stuiver MM, Van Harten WH, Geleijn E, Kieffer JM. et al. Effect of low-intensity physical activity and moderate-to-high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue and chemotherapy completion rates: results of the PACES randomized clinical trial. J Clin Oncol 2015; 33: 1918-1927
    CrossrefPubMedGoogle Scholar
  • 45 Wayne PM, Lee MS, Novakowski J. et al. Tai Chi and Qigong for cancer-related symptoms and quality of life: a systematic review and meta-analysis. J Cancer Surviv 2018; 12: 256-267
    CrossrefPubMedGoogle Scholar